Relaps/Refrakter Agresif B-hücre Non-Hodgkin Lenfomada Orelabrutinib ve Lenalidomidle Birlikte R-Mini CDOP Kullanımının Etki ve Güvenilirliği
Ying Shang1, Hongyu Zhao2, Daqi Li21Shandong First Medical University & Shandong Academy of Medical Sciences, Shandong, China2Central Hospital Affiliated to Shandong First Medical University, Shandong, China
Anahtar Kelimeler: Relpas/refrakter agresif B-hücre lenfoma, Orelabrutinib, Lenalidomid, R-mini CDOP
Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma
Ying Shang1, Hongyu Zhao2, Daqi Li21Shandong First Medical University & Shandong Academy of Medical Sciences, Shandong, China2Central Hospital Affiliated to Shandong First Medical University, Shandong, China
Keywords: Relapsed/refractory aggressive B-cell lymphoma, Orelabrutinib, Lenalidomide, R-mini CDOP
Ying Shang, Hongyu Zhao, Daqi Li. Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma. . 2023; 40(4): 284-285
Sorumlu Yazar: Daqi Li, China
Sorumlu Yazar: Daqi Li, China
| ARAÇLAR |
 Tam Metin PDF Yazdır Alıntıyı İndir RIS EndNote BibTex Medlars Procite Reference Manager E-Postala Paylaş Yazara e-posta gönder
Benzer makaleler Google Scholar |